Advanced search
Publication Cover
Patient Preference and Adherence Volume 15, 2021 - Issue
Submit an article Journal homepage
121
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Adverse Drug Reaction Reports Regarding Abnormal Behavior After Oseltamivir Use in Children as Reported by Consumers or Healthcare Professionals

Aoi Noda1 Division of Preventive Medicine and Epidemiology, Tohoku University, Tohoku Medical Megabank Organization, Sendai, Miyagi, Japan;2 Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan;3 Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Miyagi, Japan
,
Masami Tsuchiya4 Laboratory of Clinical Pharmacy, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan;5 Department of Pharmacy, Miyagi Cancer Center, Natori, Miyagi, JapanORCID Iconhttps://orcid.org/0000-0003-3846-0435
ORCID Icon,
Takamasa Sakai6 Drug Informatics, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, JapanORCID Iconhttps://orcid.org/0000-0001-9086-6999
ORCID Icon,
Taku Obara1 Division of Preventive Medicine and Epidemiology, Tohoku University, Tohoku Medical Megabank Organization, Sendai, Miyagi, Japan;2 Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan;3 Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Miyagi, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3674-1674
ORCID Icon &
Nariyasu Mano3 Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Miyagi, Japan;4 Laboratory of Clinical Pharmacy, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Miyagi, Japan
Pages 533-541 | Published online: 04 Mar 2021

References

  • Ministry of Health and Welfare. Notification no.1334: clinical investigation of medicinal products in the pediatric population. Available from: https://www.pmda.go.jp/files/000156072.pdf. Accessed November 5, 2020. Japanese.
  • Morita S. The report of health and labour sciences research grants; 2011. Available from: https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=199900758A. Accessed November 5, 2020. Japanese.
  • Rieder M. Adverse drug reactions across the age continuum: epidemiology, diagnostic challenges, prevention, and treatments. J Clin Pharmacol. 2018;58(Suppl 10):S36–S47. doi:10.1002/jcph.1115
  • Ministry of Health, Labour and Welfare. The dear healthcare professional letter. Abnormal behavior after tamiflu use. [cited March 20, 2007]. Available from: https://www.pmda.go.jp/files/000147877.pdf. Accessed November 5, 2020. Japanese.
  • Noda A, Sakai T, Obara T, et al. Characteristics of pediatric adverse drug reaction reports in the Japanese adverse drug event report database. BMC Pharmacol Toxicol. 2020;21(1):36. doi:10.1186/s40360-020-00412-7
  • Noda A, Sakai T, Tsuchiya M, Oyanagi G, Obara T, Mano N. Characteristics of adverse events following immunization reporting in children: the Japanese adverse drug event report database. Vaccines. 2020;8(3):E357. doi:10.3390/vaccines8030357
  • Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148–156. doi:10.1111/j.1365-2125.2006.02746.x
  • van Hunsel F, Talsma A, van Puijenbroek E, de Jong-van den Berg L, van Grootheest K. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case–control study. Pharmacoepidemiol Drug Saf. 2011;20(3):286–291. doi:10.1002/pds.2092
  • Inácio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol. 2017;83(2):227–246. doi:10.1111/bcp.13098
  • Yamamoto M, Kubota K, Okazaki M, et al. Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan. Patient Prefer Adherence. 2015;9:173–184. doi:10.2147/PPA.S75761
  • Ministry of Health, Labour and Welfare. Direct patient reporting of adverse drug reactions procedures for implementation. [cited March 26, 2019]. Available from: https://www.pmda.go.jp/files/000228627.pdf. Accessed November 5, 2020. Japanese.
  • The Pharmaceuticals and Medical Devices Agency. A trial study report on the actual situation of prescriptions and the effects of safety measures using receipt data. Available from: https://www.pmda.go.jp/files/000147697.pdf. Accessed November 5, 2020. Japanese.
  • The Pharmaceuticals and Medical Devices Agency. Information on reported ADR reports. Available from: https://www.pmda.go.jp/safety/reports/patients/0002.html. Accessed November 5, 2020. Japanese.
  • Al Dweik R, Stacey D, Kohen D, Yaya S. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875–883. doi:10.1111/bcp.13159
  • Danish Health Agency. Adverse drug reaction reported by consumers in Denmark — compared with reports from healthcare professionals. Available from: https://laegemiddelstyrelsen.dk/~/media/B71CB7AF2879471ABE9DCF23BF853B18.ashx. Accessed November 5, 2020.
  • McLernon DJ, Bond CM, Hannaford PC, et al. For yellow card collaboration. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals. Drug Saf. 2010;33(9):775–788. doi:10.2165/11536510-000000000-00000
  • Dweik RA, Yaya S, Stacey D, Kohen D. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol. Springerplus. 2016;5(1):213. doi:10.1186/s40064-016-1838-9
  • Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)—United States, 1991–2001. MMWR Surveill Summ. 2003;52(1):1–24.
  • World Health Organization. Paediatric age categories to be used in differentiating between listing on a model essential medicines list for children. Available from: http://archives.who.int/eml/expcom/children/Items/PositionPaperAgeGroups.pdf. Accessed November 4, 2020.
  • Sakai T, Ohtsu F, Mori C, Tanabe K, Goto N. Signal of miscarriage with aripiprazole: a disproportionality analysis of the Japanese adverse drug event report database. Drug Saf. 2017;40(11):1141–1146. doi:10.1007/s40264-017-0560-z

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.